Bayer's drug San Arbo is designed to prevent repeat strokes without significantly increasing a patient's bleeding risk compared to standard blood thinners

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.